{"log_id": 6901716195395689652, "direction": 2, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.015577, "average": 0.947492, "min": 0.561137}, "location": {"width": 231, "top": 1452, "height": 27, "left": 756}, "words": "管外一或大量的组织结合"}, {"probability": {"variance": 0.003898, "average": 0.976663, "min": 0.712124}, "location": {"width": 765, "top": 1404, "height": 37, "left": 263}, "words": "(在成年癌症患者的1期及Ⅱ期临床试验中评估了紫杉醇的药代动力学。所用"}, {"probability": {"variance": 0.000179, "average": 0.992297, "min": 0.936218}, "location": {"width": 758, "top": 1369, "height": 28, "left": 265}, "words": "剂量为单次用量15~135mg/m2,1小时静脉滴注(n=15),30~275mg/m2,6小"}, {"probability": {"variance": 0.006015, "average": 0.977002, "min": 0.524958}, "location": {"width": 702, "top": 1327, "height": 31, "left": 263}, "words": "静脉滴注36),200-275mg/m2,24小时静脉滴注(n=54)。在总清除"}, {"probability": {"variance": 0.000234, "average": 0.995061, "min": 0.908979}, "location": {"width": 724, "top": 1287, "height": 27, "left": 263}, "words": "率和分布容积方面所得数据和Ⅲ期临床研究的发现结果相符。尚未进行AIDS相"}, {"probability": {"variance": 0.011039, "average": 0.96756, "min": 0.532527}, "location": {"width": 464, "top": 1233, "height": 40, "left": 527}, "words": "波氏肉瘤患者使用紫杉醇的药代动力学研究"}, {"probability": {"variance": 0.010747, "average": 0.966789, "min": 0.407209}, "location": {"width": 686, "top": 1204, "height": 29, "left": 261}, "words": "使用紫杉醇浓度从0.150μg/ml的范围做人血清蛋白结合率的体外研究,其"}, {"probability": {"variance": 0.006053, "average": 0.98028, "min": 0.534197}, "location": {"width": 725, "top": 1161, "height": 29, "left": 264}, "words": "蛋白结合率在89%~98%之间,紫杉醇的蛋白结合率不受西咪替丁、雷尼替丁、"}, {"probability": {"variance": 0.012961, "average": 0.957477, "min": 0.584133}, "location": {"width": 254, "top": 1121, "height": 27, "left": 734}, "words": "地塞米松或苯海拉明的影响"}, {"probability": {"variance": 0.006781, "average": 0.97238, "min": 0.58911}, "location": {"width": 682, "top": 1079, "height": 31, "left": 264}, "words": "紫杉醇在火体的分布尚未充分地阐明。将紫杉醇15~275mg/m2的剂量作1"}, {"probability": {"variance": 0.010185, "average": 0.980495, "min": 0.392775}, "location": {"width": 722, "top": 1040, "height": 30, "left": 264}, "words": "小时6小时或24小时的静脉滴注后,在尿中获得的原型药物累计总量的均值"}, {"probability": {"variance": 0.000695, "average": 0.991663, "min": 0.827945}, "location": {"width": 701, "top": 998, "height": 27, "left": 264}, "words": "及SD)占给药剂量的1.3%(0.5%)~12.6%(16.2%),这说明了大量的清除"}, {"probability": {"variance": 0.005984, "average": 0.978391, "min": 0.516855}, "location": {"width": 724, "top": 957, "height": 28, "left": 264}, "words": "为非肾性清除。在5名患者中,3小时输注225~250mg/m2剂量的放射性标记的"}, {"probability": {"variance": 8e-06, "average": 0.998422, "min": 0.985052}, "location": {"width": 725, "top": 916, "height": 29, "left": 264}, "words": "紫杉醇,到120个小时,平均71%的放射性出现于粪便中,14%出现于尿中。放"}, {"probability": {"variance": 6.1e-05, "average": 0.99693, "min": 0.956717}, "location": {"width": 712, "top": 876, "height": 27, "left": 277}, "words": "射性总清除量为剂量的56%~101%平均5%放射性标记的紫杉醇出现于粪便中"}, {"probability": {"variance": 0.010527, "average": 0.974086, "min": 0.503432}, "location": {"width": 726, "top": 835, "height": 26, "left": 264}, "words": "其余的为代谢产物,主要是6a一羟基紫杉醇。人肝微粒体和组织切片体外研究"}, {"probability": {"variance": 0.009724, "average": 0.973863, "min": 0.534526}, "location": {"width": 723, "top": 794, "height": 26, "left": 266}, "words": "显示,紫杉醇通过CYP2C8代谢,主要代谢为60-羟基紫杉醇;通过CYP3A4"}, {"probability": {"variance": 0.005544, "average": 0.963597, "min": 0.630923}, "location": {"width": 656, "top": 751, "height": 29, "left": 331}, "words": "代谢为两个小的代谢产物,即32-p-羟基紫杉醇和6a-3-p-二羟基紫杉醇"}, {"probability": {"variance": 4e-06, "average": 0.998838, "min": 0.990973}, "location": {"width": 682, "top": 712, "height": 28, "left": 265}, "words": "在有不同程度肝功能的35例患者中对紫杉醇3小时输注的体内过程和毒性"}, {"probability": {"variance": 1e-05, "average": 0.998086, "min": 0.986438}, "location": {"width": 722, "top": 670, "height": 31, "left": 268}, "words": "进行了评价。与胆红素正常的患者相比,剂量为175mg/m2时,紫杉醇在血清胆"}, {"probability": {"variance": 0.000205, "average": 0.995233, "min": 0.924273}, "location": {"width": 725, "top": 631, "height": 27, "left": 266}, "words": "红素异常但≤正常上限(ULN)2倍的患者血浆中的浓度升高,但毒性的发生率"}, {"probability": {"variance": 5.8e-05, "average": 0.996787, "min": 0.965225}, "location": {"width": 725, "top": 589, "height": 27, "left": 266}, "words": "没有明显增加,严重程度没有明显加重。在血清总胆红素>ULN2倍的5例患者"}, {"probability": {"variance": 3.7e-05, "average": 0.997439, "min": 0.963973}, "location": {"width": 723, "top": 548, "height": 26, "left": 267}, "words": "中,即使在减量(110mg/m2)的情况下,重度骨髓抑制的发生率也较高,尽管"}, {"probability": {"variance": 2e-05, "average": 0.997754, "min": 0.979008}, "location": {"width": 724, "top": 507, "height": 28, "left": 267}, "words": "差异没有统计学意义,但是血浆浓度没有升高。关于肾脏功能不全对紫杉醇体内"}, {"probability": {"variance": 2e-06, "average": 0.999189, "min": 0.99552}, "location": {"width": 231, "top": 468, "height": 26, "left": 759}, "words": "过程的影响尚未进行研究"}, {"probability": {"variance": 1.7e-05, "average": 0.998414, "min": 0.977537}, "location": {"width": 608, "top": 426, "height": 28, "left": 342}, "words": "同时合用紫杉醇和其他药物之间可能的药物相互作用尚未正式研究"}, {"probability": {"variance": 0.000544, "average": 0.980813, "min": 0.947891}, "location": {"width": 56, "top": 387, "height": 24, "left": 930}, "words": "贮藏]"}, {"probability": {"variance": 0.010021, "average": 0.976683, "min": 0.529053}, "location": {"width": 421, "top": 342, "height": 31, "left": 570}, "words": "紫杉醇注射液应在25℃以下避光、密闭保存。"}, {"probability": {"variance": 0, "average": 0.99967, "min": 0.999535}, "location": {"width": 55, "top": 303, "height": 26, "left": 939}, "words": "包装"}, {"probability": {"variance": 0.001297, "average": 0.983513, "min": 0.90009}, "location": {"width": 233, "top": 260, "height": 27, "left": 759}, "words": "管制透明玻璃瓶,1瓶/盒"}], "language": 3}